Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-037310
Filing Date
2025-08-04
Accepted
2025-08-04 08:29:31
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocgn-20250630.htm   iXBRL 10-Q 1049491
2 EX-10.1 ocgn-20250630x10qxex101.htm EX-10.1 14067
3 EX-31.1 ocgn-20250630x10qxex3111.htm EX-31.1 9930
4 EX-31.2 ocgn-20250630x10qxex3121.htm EX-31.2 9650
5 EX-32.1 ocgn-20250630x10qxex3211.htm EX-32.1 7220
11 ocgn-20250630_g1.jpg GRAPHIC 27940
  Complete submission text file 0001628280-25-037310.txt   6442063

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20250630.xsd EX-101.SCH 39943
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocgn-20250630_cal.xml EX-101.CAL 60436
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocgn-20250630_def.xml EX-101.DEF 198455
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20250630_lab.xml EX-101.LAB 586172
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20250630_pre.xml EX-101.PRE 408515
76 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20250630_htm.xml XML 840283
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36751 | Film No.: 251178201
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)